•
Sep 30, 2013

Jazz Pharmaceuticals Q3 2013 Earnings Report

Total Revenue
$232M
Previous year: $176M
+31.9%
EPS
$1.78
Previous year: $1.29
+38.0%
Gross Profit
$208M
Previous year: $143M
+45.5%
Cash and Equivalents
$588M
Previous year: $190M
+210.1%
Total Assets
$2.19B
Previous year: $1.73B
+26.6%

Jazz Pharmaceuticals

Jazz Pharmaceuticals